Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of KAPA will decline by -13.05% over the next 2 Weeks and hit $1.46 by Thursday, September 24, 2026. In that time frame, KAPA's share price is expected to range between $1.15 and $1.77.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 24, 2026 | 1.15 | 1.46 | 1.77 |
| Sep 23, 2026 | 1.18 | 1.46 | 1.81 |
| Sep 22, 2026 | 1.19 | 1.48 | 1.80 |
| Sep 21, 2026 | 1.16 | 1.45 | 1.76 |
| Sep 18, 2026 | 1.26 | 1.55 | 1.85 |
| Sep 17, 2026 | 1.26 | 1.57 | 1.88 |
| Sep 16, 2026 | 1.26 | 1.57 | 1.88 |
| Sep 15, 2026 | 1.29 | 1.59 | 1.91 |
| Sep 14, 2026 | 1.22 | 1.55 | 1.86 |
| Sep 11, 2026 | 1.35 | 1.65 | 1.96 |
KAPA shares rose +1.20% in Thursday, September 10, 2026's trading session, rising from a previous close of $1.66 to move at $1.68. The stock demonstrated notable intraday movement (see KAPA's key stats for a full breakdown), fluctuating between $1.62 and $1.73, a +6.75% trading range. While recent weeks have seen some volatility, KAPA has managed to secure a -0.41% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 32.59K shares changing hands, 48.8K fewer than the previous session. This amounted to $54.76K in total market activity.
Will KAPA Continue Its Upward Trend?
According to analyst ratings and projections for KAPA, Kairos Pharma, Ltd. shares are anticipated to increase by +5.29%, potentially reaching $1.77 per share by September 24, 2026. Short-term technical indicators currently suggest a neutral sentiment for KAPA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the KAPA stock forecast, now is a good time to buy KAPA stock because its current trading price is +15.01% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on KAPA covering social and institutional perspectives.
KAPA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into KAPA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.26% to 39.81%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 40.42%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.05%, maintains a neutral outlook for the long term. Insights into KAPA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Kairos Pharma Short-Term Forecasts
KAPA Forecast For Next 5 Days
Our algorithm anticipates Kairos Pharma (KAPA) stock could hit $1.39 by Sep 17, 2026. This represents a -17.01% fall from today's price, following a -0.57% change over the past five days.
KAPA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Kairos Pharma, Ltd. (KAPA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.21, which would mean a -27.98% decrease from the current price of $1.68. Projections for this period range from a high of $1.74 to a low of $0.79.
KAPA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Kairos Pharma's price over the next three months point to a rise. KAPA stock is expected to peak at $3.48 on Sep 11, 2026 before potentially dipping to $0.87 on Nov 25, 2026. On average, KAPA is likely to trade around $1.87 in the coming 90 days.
Kairos Pharma Stock Forecast 2025
Based on our predictive models, Kairos Pharma (KAPA) is expected to trade between $0.87 and $3.48 throughout 2026. This would result in an average price of $1.82, potentially offering investors a +8.33% return from current levels.
Kairos Pharma, Ltd. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Kairos Pharma, Ltd. (KAPA) is positioned to show a strong performance in September 2026. The price is predicted to move between $1.68 and $3.48, settling at an average of $2.33. This could translate to a +38.69% gain.
October 2026
Based on current market signals, Kairos Pharma, Ltd. is projected to trend october 2026. We forecast a trading range from $1.35 to $2.23, with a likely average price of $1.82. Investors could expect a potential return of +8.33%.
November 2026
Our predictive algorithms indicate Kairos Pharma, Ltd. stock may see a shift in November 2026. The expected range spans $0.87–$2.49, with an average target of $1.74. This represents a positive outlook and a possible gain of +3.57%.
December 2026
Analyzing established trends, Kairos Pharma, Ltd. looks set to move in December 2026. Projections place the stock between $0.94 and $2.11, averaging around $1.57. This suggests a -6.55% loss from current levels.
January 2027
Market indicators suggest Kairos Pharma, Ltd. could experience notable changes during January 2027. Prices could fluctuate within $0.83 to $2.51, with a midpoint forecast of $2.07. The stock might deliver a +23.21% gain.
February 2027
Forecasting for February 2027, models estimate that Kairos Pharma, Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.40 and $1.65, averaging $1.29. This signals a cautious trajectory with potential returns around -23.21%.
March 2027
According to our latest forecast models, Kairos Pharma, Ltd. (KAPA) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $1.45, settling at an average of $1.37. This could translate to a -18.45% loss.
April 2027
Based on current market signals, Kairos Pharma, Ltd. is projected to trend april 2027. We forecast a trading range from $0.00 to $1.28, with a likely average price of $1.57. Investors could expect a potential return of -6.55%.
May 2027
Our predictive algorithms indicate Kairos Pharma, Ltd. stock may see a shift in May 2027. The expected range spans $0.00–$0.65, with an average target of $1.23. This represents a cautious outlook and a possible loss of -26.79%.
June 2027
Analyzing established trends, Kairos Pharma, Ltd. looks set to move in June 2027. Projections place the stock between $0.00 and $0.09, averaging around $1.09. This suggests a -35.12% loss from current levels.
July 2027
Market indicators suggest Kairos Pharma, Ltd. could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.68. The stock might deliver a -59.52% loss.
August 2027
Forecasting for August 2027, models estimate that Kairos Pharma, Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.69. This signals a cautious trajectory with potential returns around -58.93%.
September 2027
According to our latest forecast models, Kairos Pharma, Ltd. (KAPA) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.79. This could translate to a -52.98% loss.
KAPA's history of dividends and stock splits also plays a role in long-term investor confidence.